Sierra Summit Advisors增加了在Johnson & Johnson的股份，该公司的收益预期超过了每股2.04美元。 Sierra Summit Advisors increases stake in Johnson & Johnson, which beat earnings estimates with $2.04 per share.

Sierra Summit Advisors LLC和其他公司一直在买卖Johnson & Johnson （JNJ）的股票，Sierra Summit增加了其持有量。 Sierra Summit Advisors LLC and other firms have been buying and selling shares of Johnson & Johnson (JNJ), with Sierra Summit increasing its holdings. JNJ报告收入为每股2.04美元,打折估计数为5美元,收入为225.2亿美元,略高于预测。 JNJ reported earnings of $2.04 per share, beating estimates by $0.05, and revenue of $22.52 billion, slightly above forecasts. 分析员预期JNJ将在本年度设置10.58 EPS。 Analysts expect JNJ to post 10.58 EPS for the year. 股价为171.33美元, 目标价格为171.33美元。 The stock has a "Moderate Buy" rating and a target price of $171.33.